Yeast Beta Glucan Market Covering Prime Factors and Competitive Outlook till 2032

1
Yeast Beta Glucan Market Size to Cross USD 409 Mn
by 2032
2
Overview of Yeast Beta Glucan Market

• The yeast beta glucan market is expected to reach
  USD 409 million by 2032, according to a new
  research report by Global Market Insights Inc.
• A food substance that the Food and Drug
  Administration (FDA) considers safe and is widely
  used in foods, such as baking foods and
  beverages, premix, dairy products, cereals, and
  vegetable protein products. Furthermore, the
  rising usage of yeast beta glucan in the
  production of sports nutrition products is
  increasingly drawing interest from a growing
  number of health-conscious customers.
• The yeast beta glucan market from the insoluble
  segment is set to grow at CAGR of 10 between
  2023 to 2032, due to the increasing use of
  natural flavoring that is produced using yeast,
  coupled with prominent initiatives by various
  companies to launch new products. For instance,
  in April 2022, AIDP, Inc. stated that Puremune, a
  branded insoluble yeast beta-glucan by Immudyne
  Nutritional, received a commercial authorization
  from Health Canada as a yeast beta glucan source
  with immunomodulating effects at 30 mg per dosage.

3
Continue

• The yeast beta glucan market share from the above
  85 segment is set to cross USD 95.5 million in
  revenue by 2032, attributed to the growing demand
  for food products with functional benefits among
  the younger generations, such as millennials, is
  fueling product use. Furthermore, ongoing
  initiatives by enterprises to consolidate their
  business standing are likely to promote segment
  expansion. In January 2021, Danstar Ferment AG, a
  Lallemand Inc subsidiary, acquired Biotec
  BetaGlucans AS (BBG), a producer of high-purity
  beta glucan, to gain access to promising
  technologies in yeast-based ingredients.
• The from pharmaceutical applications segment is
  anticipated to depict more than 10.5 CAGR
  through 2032. In recent years, pharmaceutical
  companies have amplified their RD efforts to
  incorporate the immunity-boosting properties of
  yeast beta glucan in various treatments, which is
  expected to impel the market growth. For
  instance, in August 2022, Ceapro and McMaster
  University extended an ongoing collaboration to
  conduct further research on developing an
  inhalable immuno-therapeutic for treating lung
  fibrosis caused by the COVID-19 infection with
  yeast beta glucan that is purified and dried
  using PGX technology.

4
Continue

• The Europe yeast beta glucan market is slated to
  surpass USD 125 million by 2032. The EU has
  approved yeast beta-glucan as a novel food
  component in the manufacturing of beverages and a
  variety of foods. The rising popularity of health
  and wellness products, particularly nutritional
  supplements, has increased the need for yeast
  beta glucan, which is a major factor likely to
  boost the regional industry revenue growth.
  According to NCBI, 72 of adults in Poland use
  dietary supplements, with 48 consuming them on a
  regular basis.
• Notable participants in the yeast beta glucan
  market include Kerry Group, Ohly, Mitushi
  Biopharma, Aria Ingredients, Sanofi, Biorigin,
  Lallemand, and Leiber.

5
Browse Full Research Report On Yeast Beta Glucan
Market _at_ https//bit.ly/43552iw Request for a
sample of this research report _at_
https//bit.ly/43cElsC
6
Stay In Touch Website www.gminsights.com Social
Media